S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.67 (-0.12%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.67 (-0.12%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.67 (-0.12%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
S&P 500   4,310.32 (+0.31%)
DOW   34,175.08 (+0.77%)
QQQ   332.67 (-0.12%)
AAPL   173.11 (-0.05%)
MSFT   292.77 (-0.24%)
META   179.33 (-0.86%)
GOOGL   121.89 (-0.16%)
AMZN   144.31 (+0.79%)
TSLA   927.04 (-0.10%)
NVDA   189.22 (-0.58%)
NIO   20.86 (-2.07%)
BABA   92.84 (-1.44%)
AMD   100.09 (-0.91%)
MU   64.27 (-0.66%)
T   18.69 (+1.63%)
CGC   3.73 (-2.36%)
F   16.53 (+1.29%)
GE   80.27 (+0.58%)
DIS   125.59 (+1.07%)
AMC   24.46 (+1.03%)
PYPL   102.48 (+0.96%)
PFE   49.76 (+0.02%)
NFLX   247.20 (-0.77%)
NYSE:SYK

Stryker - SYK Stock Forecast, Price & News

$225.09
+0.52 (+0.23%)
(As of 08/16/2022 12:21 PM ET)
Add
Compare
Today's Range
$222.12
▼
$225.09
50-Day Range
$189.27
▼
$230.70
52-Week Range
$188.84
▼
$281.16
Volume
21,787 shs
Average Volume
1.77 million shs
Market Capitalization
$85.12 billion
P/E Ratio
41.45
Dividend Yield
1.25%
Price Target
$256.00

Stryker MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
13.8% Upside
$256.00 Price Target
Short Interest
Healthy
1.44% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.95
Upright™ Environmental Score
News Sentiment
0.10mentions of Stryker in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.70%
From $9.38 to $10.29 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.18 out of 5 stars

Medical Sector

10th out of 1,124 stocks

Surgical & Medical Instruments Industry

2nd out of 113 stocks

See Top Rated MarketRank™ Stocks Here
SYK stock logo

About Stryker (NYSE:SYK) Stock

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Stryker Stock Performance

Stryker stock opened at $224.57 on Tuesday. The stock has a 50-day simple moving average of $205.92 and a 200 day simple moving average of $235.68. The company has a quick ratio of 1.15, a current ratio of 2.00 and a debt-to-equity ratio of 0.85. Stryker has a 12-month low of $188.84 and a 12-month high of $281.16. The stock has a market capitalization of $84.92 billion, a price-to-earnings ratio of 41.36, a P/E/G ratio of 2.71 and a beta of 1.03.

Stryker (NYSE:SYK - Get Rating) last released its quarterly earnings results on Tuesday, July 26th. The medical technology company reported $2.25 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.28 by ($0.03). Stryker had a net margin of 11.79% and a return on equity of 23.34%. During the same period in the prior year, the firm earned $2.25 earnings per share. On average, research analysts anticipate that Stryker will post 9.38 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 31st. Investors of record on Friday, September 30th will be given a $0.695 dividend. The ex-dividend date is Thursday, September 29th. This represents a $2.78 dividend on an annualized basis and a yield of 1.24%. Stryker's payout ratio is 51.20%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Cowen lowered their price target on Stryker from $305.00 to $233.00 and set an "outperform" rating on the stock in a report on Friday, July 22nd. Piper Sandler lowered their price objective on shares of Stryker from $290.00 to $250.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 27th. Truist Financial raised their price objective on shares of Stryker to $220.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 27th. Bank of America downgraded shares of Stryker from a "buy" rating to a "neutral" rating in a research note on Monday, July 11th. Finally, Stifel Nicolaus lowered their price objective on shares of Stryker from $285.00 to $245.00 in a research note on Monday, July 18th. Five investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $256.00.

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

August 15, 2022 | businesswire.com
Global Large Joint Devices Market Report Suite 2022-2028 - ResearchAndMarkets.com - Business Wire
August 10, 2022 | americanbankingnews.com
Financial Survey: Stryker (NYSE:SYK) and Venus Concept (NASDAQ:VERO)
August 10, 2022 | americanbankingnews.com
Stryker Co. (NYSE:SYK) Receives $256.00 Average PT from Analysts
August 3, 2022 | benzinga.com
Stryker declares a $0.695 per share quarterly dividend - Benzinga
August 3, 2022 | marketwatch.com
Stryker Corp. stock falls Tuesday, still outperforms market - MarketWatch
August 1, 2022 | americanbankingnews.com
Stryker (NYSE:SYK) Raised to Buy at Edward Jones
July 31, 2022 | americanbankingnews.com
Oppenheimer Weighs in on Stryker Co.'s Q4 2022 Earnings (NYSE:SYK)
July 29, 2022 | americanbankingnews.com
Robert W. Baird Lowers Stryker (NYSE:SYK) Price Target to $240.00
July 29, 2022 | americanbankingnews.com
Stryker Co. (NYSE:SYK) Forecasted to Earn Q3 2022 Earnings of $2.21 Per Share
July 28, 2022 | finance.yahoo.com
Outlook on the Minimally Invasive Surgical Systems Global Market to 2030 - Featuring Medtronic, Intuitive Surgical and Stryker Among Others - Yahoo Finance
July 28, 2022 | finance.yahoo.com
Stryker's (NYSE:SYK) 9.1% CAGR outpaced the company's earnings growth over the same five-year period
July 28, 2022 | americanbankingnews.com
Truist Financial Increases Stryker (NYSE:SYK) Price Target to $220.00
July 28, 2022 | americanbankingnews.com
Wells Fargo & Company Cuts Stryker (NYSE:SYK) Price Target to $237.00
July 28, 2022 | americanbankingnews.com
Stryker (NYSE:SYK) Price Target Cut to $255.00 by Analysts at Royal Bank of Canada
July 28, 2022 | americanbankingnews.com
Stryker (NYSE:SYK) Price Target Lowered to $250.00 at Piper Sandler
July 28, 2022 | nasdaq.com
Stryker Corp. Q2 Profit Increases, but misses estimates
July 27, 2022 | finance.yahoo.com
Stryker's Q2 Earnings Miss Street View On Forex & Inflation Pressure
July 27, 2022 | finance.yahoo.com
Stryker's (SYK) Q2 Earnings and Revenues Miss Estimates
July 26, 2022 | seekingalpha.com
Stryker Corporation (SYK) CEO Kevin Lobo on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha
July 26, 2022 | finance.yahoo.com
Stryker reports second quarter 2022 operating results - Yahoo Finance
July 26, 2022 | finance.yahoo.com
Stryker (SYK) Lags Q2 Earnings and Revenue Estimates
July 26, 2022 | seekingalpha.com
Stryker 2022 EPS estimate below consensus as supply chain challenges, inflation weigh - Seeking Alpha
July 26, 2022 | investors.com
Stryker Stock: CEO Is Confident In Sales Despite Dollar Squeeze On Profits | Investor's Business Daily - Investor's Business Daily
July 26, 2022 | finance.yahoo.com
Stryker reports second quarter 2022 operating results
July 26, 2022 | americanbankingnews.com
Stryker (NYSE:SYK) PT Lowered to $233.00 at Cowen
See More Headlines
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Company Calendar

Ex-Dividend for 7/29 Dividend
6/29/2022
Last Earnings
7/26/2022
Dividend Payable
7/29/2022
Today
8/16/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:SYK
CUSIP
86366710
CIK
310764
Web
www.strykercorp.com
Phone
(269) 385-2600
Fax
269-385-1062
Employees
46,000
Year Founded
1941

Price Target and Rating

Average Stock Price Forecast
$256.00
High Stock Price Forecast
$305.00
Low Stock Price Forecast
$205.00
Forecasted Upside/Downside
+13.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
15 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$5.43
Trailing P/E Ratio
41.45
Forward P/E Ratio
24.00
P/E Growth
2.71
Net Income
$1.99 billion
Net Margins
11.79%
Pretax Margin
13.38%
Return on Equity
23.34%
Return on Assets
9.90%

Debt

Debt-to-Equity Ratio
0.85
Current Ratio
2.00
Quick Ratio
1.15

Sales & Book Value

Annual Sales
$17.11 billion
Price / Sales
4.98
Cash Flow
$11.93 per share
Price / Cash Flow
18.86
Book Value
$39.42 per share
Price / Book
5.71

Miscellaneous

Outstanding Shares
378,150,000
Free Float
353,574,000
Market Cap
$85.12 billion
Optionable
Optionable
Beta
1.03

Social Links


Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 5 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SYK shares.
View SYK analyst ratings or view top-rated stocks.

What is Stryker's stock price forecast for 2022?

15 equities research analysts have issued twelve-month price targets for Stryker's shares. Their SYK share price forecasts range from $205.00 to $305.00. On average, they expect the company's stock price to reach $256.00 in the next year. This suggests a possible upside of 14.0% from the stock's current price.
View analysts price targets for SYK or view top-rated stocks among Wall Street analysts.

How have SYK shares performed in 2022?

Stryker's stock was trading at $267.42 at the beginning of the year. Since then, SYK shares have decreased by 16.0% and is now trading at $224.57.
View the best growth stocks for 2022 here.

When is Stryker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our SYK earnings forecast.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) posted its quarterly earnings results on Tuesday, July, 26th. The medical technology company reported $2.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.28 by $0.03. Stryker had a trailing twelve-month return on equity of 23.34% and a net margin of 11.79%. During the same quarter in the prior year, the business posted $2.25 earnings per share.
Read the conference call transcript.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Wednesday, August 3rd. Stockholders of record on Friday, September 30th will be given a dividend of $0.695 per share on Monday, October 31st. This represents a $2.78 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date of this dividend is Thursday, September 29th.
Read our dividend analysis for SYK.

Is Stryker a good dividend stock?

Stryker (NYSE:SYK) pays an annual dividend of $2.78 per share and currently has a dividend yield of 1.25%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 51.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 27.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY 2022 earnings guidance on Tuesday, August, 2nd. The company provided earnings per share guidance of $9.30-$9.50 for the period, compared to the consensus estimate of $9.63. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a number of institutional and retail investors. Top institutional investors include Greenleaf Trust (5.26%), State Street Corp (3.65%), Franklin Resources Inc. (1.37%), Northern Trust Corp (0.93%), Massachusetts Financial Services Co. MA (0.90%) and Ontario Teachers Pension Plan Board (0.68%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar, Timothy J Scannell and Timothy J Scannell.
View institutional ownership trends.

How do I buy shares of Stryker?

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $224.57.

How much money does Stryker make?

Stryker (NYSE:SYK) has a market capitalization of $84.92 billion and generates $17.11 billion in revenue each year. The medical technology company earns $1.99 billion in net income (profit) each year or $5.43 on an earnings per share basis.

How many employees does Stryker have?

The company employs 46,000 workers across the globe.

Does Stryker have any subsidiaries?
The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
When was Stryker founded?

Stryker was founded in 1941.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The official website for the company is www.strykercorp.com. The medical technology company can be reached via phone at (269) 385-2600, via email at katherine.owen@stryker.com, or via fax at 269-385-1062.

This page (NYSE:SYK) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.